Global Cardiopulmonary Auto transfusion System Market by Type (On-Pump Transfusion Device, Off-Pump Transfusion Device), By Application (Hospitals, Ambulatory Surgical Centers, Cardiac Research Centers) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
The Global Cardiopulmonary Auto Transfusion System Market size is expected to grow from USD $1.4 billion in 2020 to USD $XX billion by 2028, at a CAGR of 7.5% during the forecast period (2021-2028). The growth of the market can be attributed to the increasing number of cardiovascular diseases and growing awareness about its prevention. Cardiopulmonary autotransfusion systems are also increasingly being used in minimally invasive surgeries due to their ability for rapid replacement of blood volume lost during surgery while preventing post-surgical complications such as bleeding and anemia
Cardiopulmonary Auto Transfusion Systems are devices that have been developed to automatically transfuse blood or other fluids. These systems can use either a pump-driven system, where the prime mover is an external electric motor and the fluid storage reservoir is outside of the patient's body, or an off-pump system in which there is no need for any mechanical intervention from an external power source.
On the basis of Types, the market is segmented into On-Pump Transfusion Device, Off-Pump Transfusion Devices.
On-Pump Transfusion Device:
An On-Pump Transfusion Device is a device that transfuses blood into the body and removes it from the patient. The on-pump system of cardiopulmonary autotransfusion helps in removing any clots or air bubbles present in the bloodstream, which could otherwise lead to strokes or heart attacks.
Off-Pump Transfusion Devices:
Off-Pump Transfusion Devices are devices that provide transfusions to patients without the need for a heart-lung machine. These systems reduce blood loss and can be used in critical care settings instead of open-chest surgery. They are also known as intermittent static or pulsatile flow oxygenator, percutaneous cardiopulmonary bypass (CPB), extracorporeal circulation (ECC) device, cardiac support device, or artificial lung.
On the basis of Application, the market is segmented into Hospitals and Ambulatory Surgical Centers. Off-Pump Transfusion Devices are mostly used in hospitals, while on-pump systems are more commonly found in ambulatory surgical centers.
On the basis of Region, the market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The North American market is expected to lead the global market during the forecast period. The steady rise in the geriatric population is one of the major driving forces for this region’s growth
The Asia Pacific and Middle East & Africa markets are anticipated to grow at a healthy CAGR due to favorable demographics, increasing focus on cardiopulmonary care services from healthcare providers, and rising adoption rate of automated transfusion devices in these regions.
Growth Factors For The Global Cardiopulmonary Auto Transfusion System Market:
- Increasing incidences of transfusion-related acute lung injury.
- A rise in demand for off-pump cardiac surgery procedures and an increasing population with cardiovascular diseases such as hypertension, diabetes mellitus, valvular disease are some factors driving the growth of this market.
- The increase in the number of surgeries performed by cardiothoracic surgeons is a major driver for the growth of this market globally. In addition to that increased incidence rates and prolonged hospital stays due to postoperative care & recovery also boost its growth prospects over the forecast period from 2021 - 2028.
Up Market Research published a new report titled “Cardiopulmonary Auto transfusion System Market research report which is segmented by Types (On-Pump Transfusion Device, Off-Pump Transfusion Device), By Applications (Hospitals, Ambulatory Surgical Centers, Cardiac Research Centers), By Players/Companies Haemonetics, Medtronic, LivaNova, Fresenius, Terumo Interventional Systems, Wandong Health Sources, Redax, Global Blood Resources, Atrium Medical, Stryker”.
Report Scope
| Report Attributes | Report Details |
| Report Title | Cardiopulmonary Auto transfusion System Market Research Report |
| By Type | On-Pump Transfusion Device, Off-Pump Transfusion Device |
| By Application | Hospitals, Ambulatory Surgical Centers, Cardiac Research Centers |
| By Companies | Haemonetics, Medtronic, LivaNova, Fresenius, Terumo Interventional Systems, Wandong Health Sources, Redax, Global Blood Resources, Atrium Medical, Stryker |
| Regions Covered | North America, Europe, APAC, Latin America, MEA |
| Base Year | 2020 |
| Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
| Forecast Year | 2028 |
| Number of Pages | 242 |
| Number of Tables & Figures | 170 |
| Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Cardiopulmonary Auto transfusion System Market Report Segments:
The market is segmented by Type On-Pump Transfusion Device, Off-Pump Transfusion Device and By Application Hospitals, Ambulatory Surgical Centers, Cardiac Research Centers.
Some of the companies that are profiled in this report are:
- Haemonetics
- Medtronic
- LivaNova
- Fresenius
- Terumo Interventional Systems
- Wandong Health Sources
- Redax
- Global Blood Resources
- Atrium Medical
- Stryker
Cardiopulmonary Auto transfusion System Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Cardiopulmonary Auto transfusion System Market
Overview of the regional outlook of the Cardiopulmonary Auto transfusion System Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Cardiopulmonary Auto transfusion System Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Cardiopulmonary Auto transfusion System Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
- By Type:
1. On-Pump Transfusion Device
2. Off-Pump Transfusion Device
7. By Application:1. Hospitals
2. Ambulatory Surgical Centers
3. Cardiac Research Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cardiopulmonary Auto transfusion System Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Cardiopulmonary Auto transfusion System Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cardiopulmonary Auto transfusion System Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cardiopulmonary Auto transfusion System Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cardiopulmonary Auto transfusion System Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cardiopulmonary Auto transfusion System Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cardiopulmonary Auto transfusion System Market Size & Forecast, 2018-2028
4.5.1 Cardiopulmonary Auto transfusion System Market Size and Y-o-Y Growth
4.5.2 Cardiopulmonary Auto transfusion System Market Absolute $ Opportunity
Chapter 5 Global Cardiopulmonary Auto transfusion System Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Cardiopulmonary Auto transfusion System Market Size Forecast by Type
5.2.1 On-Pump Transfusion Device
5.2.2 Off-Pump Transfusion Device
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Cardiopulmonary Auto transfusion System Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Cardiopulmonary Auto transfusion System Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Ambulatory Surgical Centers
6.2.3 Cardiac Research Centers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cardiopulmonary Auto transfusion System Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cardiopulmonary Auto transfusion System Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Cardiopulmonary Auto transfusion System Analysis and Forecast
9.1 Introduction
9.2 North America Cardiopulmonary Auto transfusion System Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Cardiopulmonary Auto transfusion System Market Size Forecast by Type
9.6.1 On-Pump Transfusion Device
9.6.2 Off-Pump Transfusion Device
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Cardiopulmonary Auto transfusion System Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Ambulatory Surgical Centers
9.10.3 Cardiac Research Centers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Cardiopulmonary Auto transfusion System Analysis and Forecast
10.1 Introduction
10.2 Europe Cardiopulmonary Auto transfusion System Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Cardiopulmonary Auto transfusion System Market Size Forecast by Type
10.6.1 On-Pump Transfusion Device
10.6.2 Off-Pump Transfusion Device
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Cardiopulmonary Auto transfusion System Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Ambulatory Surgical Centers
10.10.3 Cardiac Research Centers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Cardiopulmonary Auto transfusion System Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Cardiopulmonary Auto transfusion System Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Cardiopulmonary Auto transfusion System Market Size Forecast by Type
11.6.1 On-Pump Transfusion Device
11.6.2 Off-Pump Transfusion Device
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Cardiopulmonary Auto transfusion System Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Ambulatory Surgical Centers
11.10.3 Cardiac Research Centers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Cardiopulmonary Auto transfusion System Analysis and Forecast
12.1 Introduction
12.2 Latin America Cardiopulmonary Auto transfusion System Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Cardiopulmonary Auto transfusion System Market Size Forecast by Type
12.6.1 On-Pump Transfusion Device
12.6.2 Off-Pump Transfusion Device
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Cardiopulmonary Auto transfusion System Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Ambulatory Surgical Centers
12.10.3 Cardiac Research Centers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Cardiopulmonary Auto transfusion System Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Cardiopulmonary Auto transfusion System Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Cardiopulmonary Auto transfusion System Market Size Forecast by Type
13.6.1 On-Pump Transfusion Device
13.6.2 Off-Pump Transfusion Device
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Cardiopulmonary Auto transfusion System Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Ambulatory Surgical Centers
13.10.3 Cardiac Research Centers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cardiopulmonary Auto transfusion System Market: Competitive Dashboard
14.2 Global Cardiopulmonary Auto transfusion System Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Haemonetics
14.3.2 Medtronic
14.3.3 LivaNova
14.3.4 Fresenius
14.3.5 Terumo Interventional Systems
14.3.6 Wandong Health Sources
14.3.7 Redax
14.3.8 Global Blood Resources
14.3.9 Atrium Medical
14.3.10 Stryker
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cardiopulmonary Auto transfusion System Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cardiopulmonary Auto transfusion System Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cardiopulmonary Auto transfusion System Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cardiopulmonary Auto transfusion System Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cardiopulmonary Auto transfusion System Market Size & Forecast, 2018-2028
4.5.1 Cardiopulmonary Auto transfusion System Market Size and Y-o-Y Growth
4.5.2 Cardiopulmonary Auto transfusion System Market Absolute $ Opportunity
Chapter 5 Global Cardiopulmonary Auto transfusion System Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Cardiopulmonary Auto transfusion System Market Size Forecast by Type
5.2.1 On-Pump Transfusion Device
5.2.2 Off-Pump Transfusion Device
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Cardiopulmonary Auto transfusion System Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Cardiopulmonary Auto transfusion System Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Ambulatory Surgical Centers
6.2.3 Cardiac Research Centers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cardiopulmonary Auto transfusion System Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cardiopulmonary Auto transfusion System Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Cardiopulmonary Auto transfusion System Analysis and Forecast
9.1 Introduction
9.2 North America Cardiopulmonary Auto transfusion System Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Cardiopulmonary Auto transfusion System Market Size Forecast by Type
9.6.1 On-Pump Transfusion Device
9.6.2 Off-Pump Transfusion Device
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Cardiopulmonary Auto transfusion System Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Ambulatory Surgical Centers
9.10.3 Cardiac Research Centers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Cardiopulmonary Auto transfusion System Analysis and Forecast
10.1 Introduction
10.2 Europe Cardiopulmonary Auto transfusion System Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Cardiopulmonary Auto transfusion System Market Size Forecast by Type
10.6.1 On-Pump Transfusion Device
10.6.2 Off-Pump Transfusion Device
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Cardiopulmonary Auto transfusion System Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Ambulatory Surgical Centers
10.10.3 Cardiac Research Centers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Cardiopulmonary Auto transfusion System Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Cardiopulmonary Auto transfusion System Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Cardiopulmonary Auto transfusion System Market Size Forecast by Type
11.6.1 On-Pump Transfusion Device
11.6.2 Off-Pump Transfusion Device
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Cardiopulmonary Auto transfusion System Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Ambulatory Surgical Centers
11.10.3 Cardiac Research Centers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Cardiopulmonary Auto transfusion System Analysis and Forecast
12.1 Introduction
12.2 Latin America Cardiopulmonary Auto transfusion System Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Cardiopulmonary Auto transfusion System Market Size Forecast by Type
12.6.1 On-Pump Transfusion Device
12.6.2 Off-Pump Transfusion Device
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Cardiopulmonary Auto transfusion System Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Ambulatory Surgical Centers
12.10.3 Cardiac Research Centers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Cardiopulmonary Auto transfusion System Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Cardiopulmonary Auto transfusion System Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Cardiopulmonary Auto transfusion System Market Size Forecast by Type
13.6.1 On-Pump Transfusion Device
13.6.2 Off-Pump Transfusion Device
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Cardiopulmonary Auto transfusion System Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Ambulatory Surgical Centers
13.10.3 Cardiac Research Centers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cardiopulmonary Auto transfusion System Market: Competitive Dashboard
14.2 Global Cardiopulmonary Auto transfusion System Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Haemonetics
14.3.2 Medtronic
14.3.3 LivaNova
14.3.4 Fresenius
14.3.5 Terumo Interventional Systems
14.3.6 Wandong Health Sources
14.3.7 Redax
14.3.8 Global Blood Resources
14.3.9 Atrium Medical
14.3.10 Stryker
Segments Covered in the Report
The global Cardiopulmonary Auto transfusion System market has been segmented based on
By Types
The global Cardiopulmonary Auto transfusion System market has been segmented based on
By Types
- On-Pump Transfusion Device
- Off-Pump Transfusion Device
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Research Centers
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- Haemonetics
- Medtronic
- LivaNova
- Fresenius
- Terumo Interventional Systems
- Wandong Health Sources
- Redax
- Global Blood Resources
- Atrium Medical
- Stryker
Our Clients
Related Reports
Some other reports from this category!
